Market Research Logo

Gastrointestinal Drugs Market Global Briefing 2017Including: Antiulcerants, Vitamin And Minerals, Antacids, Antiemetics And Antinauseants, Antiobesity, AntidiarrhoealsCovering: Takeda Pharmaceuticals, Allergan Plc., Novo Nordisk A/S, AstraZeneca Plc., Joh

Gastrointestinal Drugs Market Global Briefing 2017Including: Antiulcerants, Vitamin And Minerals, Antacids, Antiemetics And Antinauseants, Antiobesity, AntidiarrhoealsCovering: Takeda Pharmaceuticals, Allergan Plc., Novo Nordisk A/S, AstraZeneca Plc., Johnson & Johnson, Bayer AG, Otsuka Pharmaceutical Co., Ltd.

The global gastrointestinal drugs market is expected to reach around $60 billion in 2020. This can be attributed to the expected increase in prevalence of obesity and digestive diseases globally.

Gastrointestinal Drugs Market Global Briefing provides strategists, marketers and senior management with the critical information they need to assess the global gastrointestinal drugs sector.

Reasons to Purchase

  • Get up to date information available on the gastrointestinal drugs market globally.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Gastrointestinal Drugs Market Global Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the gastrointestinal drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the gastrointestinal drugs market and suggests approaches.

Scope

Markets Covered: Antiulcerants, Vitamin And Minerals, Antacids, Antiemetics And Antinauseants, Antiobesity, Antidiarrhoeals
Companies Mentioned: Takeda Pharmaceuticals, Allergan Plc., Novo Nordisk A/S, AstraZeneca Plc., Johnson & Johnson, Bayer AG, Otsuka Pharmaceutical Co., Ltd.
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Gastrointestinal Drugs Market Characteristics
Gastrointestinal Drugs Market Historic Growth
Gastrointestinal Drugs Market Forecast Growth
Gastrointestinal Drugs Market Segmentation
Global Gastrointestinal Drugs Market, Split By Segments, 2016, $ Billion
Antiulcerants
Vitamins And Minerals
Antacids
Antiemetics And Antinauseants
Antiobesity
Antidiarrhoeals
Global Gastrointestinal Drugs Market, Historic and Forecast, Split By Segments, 2012-2020
Gastrointestinal Drugs Market Geography Regional and Country Comparison
Global Gastrointestinal Drugs Market, Split By Regions, 2016
Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Global Gastrointestinal Drugs Market, Split By Country, 2016
Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Gastrointestinal Drugs Market Competitive Landscape
Takeda Pharmaceuticals
Allergan Plc.
Novo Nordisk A/S
AstraZeneca Plc.
Johnson & Johnson
Bayer AG
Otsuka Pharmaceutical Co., Ltd.
Takeda Pharmaceuticals
Allergan
Novo Nordisk
Gastrointestinal Drugs Market Key Mergers And Acquisitions
Valeant Acquired Salix Pharmaceuticals
Celgene Acquired Receptos
Shire Acquired Dyax Corp.
Shire Acquired NPS Pharmaceuticals
Allergan Acquired AstraZeneca’s IBD Drug
Shire Acquired Meritage Pharma
Zydus Acquired Albert David
Gastrointestinal Drugs Market Trends And Strategies
Tranexamic Acid To Treat Gastrointestinal Bleeding
Increasing R&D Activities
Cost-effective Biosimilars To Treat Gastrointestinal Diseases
Appendix
NAICS Definitions Of Industry Covered In This Report
Definition Of Market Covered In This Report
Abbreviations
Currencies
Research Methodology
Research Inquiries
The Business Research Company
List of Figures
Figure 1: Global Gastrointestinal Drugs Market, Historic Market Size, 2012-2016, $ Billion
Figure 2: Global Gastrointestinal Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Gastrointestinal Drugs Market, Split By Segments, 2016, $ Billion
Figure 4: Global Gastrointestinal Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020
Figure 5: Global Gastrointestinal Drugs Market, Split By Region, 2016, $ Billion
Figure 6: Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Figure 7: Global Gastrointestinal Drugs Market, Split By Country, 2016, $ Billion
Figure 8: Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Figure 9: Global Gastrointestinal Drugs Market, Key Competitor Market Shares, 2016, Percentage (%)
List of Tables
Table 1: Global Gastrointestinal Drugs Market, Historic Market Size, 2012-2016, $ Billion
Table 2: Global Gastrointestinal Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Gastrointestinal Drugs Market, Split By Segments, 2016, $ Billion
Table 4: Global Gastrointestinal Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020
Table 5: Global Gastrointestinal Drugs Market, Split By Region, 2016, $ Billion
Table 6: Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Table 7: Global Gastrointestinal Drugs Market, Split By Country, 2016, $ Billion
Table 8: Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Table 9: Global Gastrointestinal Drugs Market, Key Competitor Market Shares, 2016, Percentage (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report